No free passes: FDA tightens rule against Foreign Tobacco Manufactures

Date:

Share post:

The U.S. Food and Drug Administration (FDA)  issued a proposed rule aimed at strengthening oversight of foreign tobacco product manufacturers and blocking illegal products from entering the United States.

The proposed rule, titled “Establishment Registration and Product Listing for Tobacco Products,” would eliminate existing regulatory gaps by requiring foreign tobacco manufacturers to register their establishments and list their products with the FDAstandard,already required for domestic companies.

By implementing these uniform requirements, the FDA aims to proactively identify and intercept unauthorized tobacco imports, with a specific focus on youth-appealing, illicit e-cigarettes. The rule will also enhance the agency’s ability to conduct systematic, on-site compliance inspections of manufacturing facilities located outside the United States.

Under the new framework, manufacturers must electronically submit granular product details, including nicotine concentrations, e-liquid volumes, battery capacities, and characterizing flavors. Additionally, companies will be required to maintain comprehensive labeling and advertising records for at least four years to ensure public health compliance.

The public is invited to submit comments on the proposed rule until September 14, 2026.

Written by: Pragna Biswas

Graphics by: Pramit Hazra

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

MSD Inaugurates New Technology Centre in Hyderabad to Drive Global Healthcare Innovation and Digital Capabilities

MSD (Merck & Co., Inc.), one of the world's leading global life sciences companies, has officially inaugurated its...

Bharat Technology Announces BT-PHARMACON 2K26 with Focus on Indigenous Pharma Innovation

Bharat Technology is set to organise BT-PHARMACON 2K26, an ANRF-sponsored national conference on September 26–27, 2026, at the Eastern Zonal...

ChrysCapital to Acquire 20-25% Stake in Linux Laboratories for ₹600 Crore

Private equity firm ChrysCapital is all set to acquire a strategic stake in Linux Laboratories, a Chennai-based specialty pharmaceutical company focused on central nervous...

India Spotlights Massive Health Workforce Expansion at WHO RC79; SEARO Adopts Historic Dili Declaration

The Ministerial Roundtable addressing on"Human Resources for Health: Equity in Specialized Care" at the 79th Session of the WHO Regional...